Home  |  Contact

Cellosaurus HCC78-TR (CVCL_UJ33)

[Text version]

Cell line name HCC78-TR
Accession CVCL_UJ33
Resource Identification Initiative To cite this cell line use: HCC78-TR (RRID:CVCL_UJ33)
Comments Selected for resistance to: ChEBI; CHEBI:91338; 5-chloro-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine (TAE684).
Sequence variations SLC34A2-ROS1 gene fusion (from parent cell line).
Homozygous for CDKN2A p.Arg58Ter (c.172C>T) (p.Pro72Leu; c.215C>T) (ClinVar=VCV000376310) (from parent cell line).
Homozygous for TP53 p.Ser241Phe (c.722C>T) (ClinVar=VCV000012359) (from parent cell line).
Disease Lung adenocarcinoma (NCIt: C3512)
Derived from metastatic site: Pleural effusion.
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_2061 (HCC78)
Sex of cell Male
Age at sampling 65Y
Category Cancer cell line
Publications

PubMed=24349229; DOI=10.1371/journal.pone.0082236
Davies K.D., Mahale S., Astling D.P., Aisner D.L., Le A.T., Hinz T.K., Vaishnavi A., Bunn P.A. Jr., Heasley L.E., Tan A.-C., Camidge D.R., Varella-Garcia M., Doebele R.C.
Resistance to ROS1 inhibition mediated by EGFR pathway activation in non-small cell lung cancer.
PLoS ONE 8:E82236-E82236(2013)

Cross-references
Other Wikidata; Q93983894
Entry history
Entry creation25-Feb-2019
Last entry update02-Jul-2020
Version number4